University Of North Carolina At Chapel Hill Scientists Find Breast Cancer Gene Required To Correct Certain GeneticDamage

August 13, 1998

CHAPEL HILL - A tumor-suppressor gene involved in breast and ovarian cancer susceptibility plays a central role in one of the body's most important mechanisms for repairing DNA when that genetic material becomes damaged, University of North Carolina at Chapel Hill researchers have discovered.

Using specially altered mouse embryo cells deficient in the gene BRCA1, the scientists found the gene directly or indirectly participates in what is called transcription-coupled repair.

"BRCA1's exact role is currently unknown, but it seems to be involved in a variety of cellular functions," said Dr. Steven A. Leadon, professor of radiation oncology at the UNC-CH School of Medicine. "This new work is important for two reasons. First, it provides probably the most direct evidence that BRCA1 is involved in DNA repair. Second, it will give us and others a useful assay, or test, to look at functional changes in the gene."

Such information is critical to knowing how cancer starts and how it might be prevented or treated more effectively, he said. Leadon compared it to understanding what various parts of a car engine do before being able to fix it.

A report on the research appears in the Aug. 14 issue of the journal Science. Besides Leadon, a member of the UNC Lineberger Comprehensive Cancer Center, authors are graduate student Lori Gowen, technicians Anna V. Avrutskaya and Anne M. Latour and Dr. Beverly H. Koller, research assistant professor of medicine.

Leadon said his laboratory has studied transcription-coupled repair for more than a decade. In that process, damage to active genes, which continuously produce proteins critical to cell function, are repaired more rapidly than damage in inactive or less active genes.

"So the cell has prioritized which regions of the genome, or total set of genes, it wants to fix first and does it through transcription-coupled repair," he said.

Gowen, Leadon and the others exposed the altered cells to three insults - ionizing radiation, hydrogen peroxide and ultraviolet light -- known to injure DNA in different ways. They then compared how well an active "housekeeping" gene known as DHFR could be repaired in the presence of either functioning BRCA1 or non-functioning BRCA1.

"We found that the normal BRCA1 gene is required for transcription-coupled repair of both ionizing radiation and hydrogen peroxide-induced damage, but not ultraviolet light damage," Gowen said. "That means it is needed to repair oxidative DNA damage when this damage occurs in active genes."

Scientists discovered the BRCA1 gene by studying genetic material from families in which breast cancer was hereditary, Gowen said. Since then, a second breast cancer gene, BRCA2, has been identified, and researchers have begun to suspect several others also promote cancer when not working properly.

How might the new UNC-CH findings affect medical research on humans? "This is the first direct evidence of a function for this tumor-suppressor gene, and it helps to explain how the gene may be involved in cancer," she said.
-end-
Note: Leadon can be reached at (919) 966-7713. Gowen can be reached at (919) 962-2159.
-end-


University of North Carolina at Chapel Hill

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.